Jiangsu Lanfeng Bio-chemical Co.,Ltd

SZSE:002513 Stock Report

Market Cap: CN¥2.2b

Jiangsu Lanfeng Bio-chemicalLtd Past Earnings Performance

Past criteria checks 0/6

Jiangsu Lanfeng Bio-chemicalLtd has been growing earnings at an average annual rate of 5.1%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 6% per year.

Key information

5.1%

Earnings growth rate

8.1%

EPS growth rate

Chemicals Industry Growth12.1%
Revenue growth rate6.0%
Return on equity-4,777.9%
Net Margin-15.9%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) Stock Catapults 107% Though Its Price And Business Still Lag The Industry

Nov 09
Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) Stock Catapults 107% Though Its Price And Business Still Lag The Industry

Benign Growth For Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) Underpins Its Share Price

Sep 25
Benign Growth For Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) Underpins Its Share Price

Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Jun 07
Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

The Market Doesn't Like What It Sees From Jiangsu Lanfeng Bio-chemical Co.,Ltd's (SZSE:002513) Revenues Yet As Shares Tumble 26%

Feb 29
The Market Doesn't Like What It Sees From Jiangsu Lanfeng Bio-chemical Co.,Ltd's (SZSE:002513) Revenues Yet As Shares Tumble 26%

Revenue & Expenses Breakdown

How Jiangsu Lanfeng Bio-chemicalLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:002513 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242,405-38118368
30 Jun 242,064-38019949
31 Mar 241,738-34817140
31 Dec 231,742-33217415
30 Sep 231,117-44515815
30 Jun 231,148-41114014
31 Mar 231,388-33611913
01 Jan 231,445-32110412
30 Sep 221,449-4611375
30 Jun 221,627-4791598
31 Mar 221,549-49217511
01 Jan 221,444-49117513
30 Sep 211,349-3815715
30 Jun 211,4041115612
31 Mar 211,4383115514
31 Dec 201,3421517716
30 Sep 201,398-53338723
30 Jun 201,295-54839930
31 Mar 201,378-54542132
31 Dec 191,504-51742535
30 Sep 191,518-81232737
30 Jun 191,351-88438437
31 Mar 191,395-88939341
31 Dec 181,481-87541045
30 Sep 181,696-9340655
30 Jun 181,918532682
31 Mar 181,9164234670
31 Dec 171,8513534258
30 Sep 171,73511330934
30 Jun 171,6281043350
31 Mar 171,507963190
31 Dec 161,4571073170
30 Sep 161,263582620
30 Jun 161,11542570
31 Mar 161,038-322440
31 Dec 151,010-692340
30 Sep 151,067-632020
30 Jun 151,144-491780
31 Mar 151,253-451550
31 Dec 141,252-371370
30 Sep 141,277-191310
30 Jun 141,322-41340
31 Mar 141,34581470
31 Dec 131,372211550

Quality Earnings: 002513 is currently unprofitable.

Growing Profit Margin: 002513 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 002513 is unprofitable, but has reduced losses over the past 5 years at a rate of 5.1% per year.

Accelerating Growth: Unable to compare 002513's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 002513 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-5.3%).


Return on Equity

High ROE: 002513 has a negative Return on Equity (-4777.92%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies